Novartis’ top lawyer resigns in wake of Trump scandal Says $100,000-per-month contract with president’s lawyer was “legal but an error” Read More
Janssen acquires BeneVir Biopharm to advance immunotherapy regimens BeneVir engineers oncolytic viruses tailored to infect and destroy cancer cells Read More
Novartis’ biosimilar rituximab delayed in US Rejection is another win for drugs’ originator Roche Read More
Merck’s MS treatment shows promise in new data HRA and HRA + DAT patients showed responses to Mavenclad that were generally better than previous outcomes in study population Read More